These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9834225)

  • 21. Laboratory Testing for von Willebrand Factor Collagen Binding (VWF:CB).
    Favaloro EJ; Mohammed S
    Methods Mol Biol; 2017; 1646():417-433. PubMed ID: 28804845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.
    Girma JP; Kalafatis M; Piétu G; Lavergne JM; Chopek MW; Edgington TS; Meyer D
    Blood; 1986 May; 67(5):1356-66. PubMed ID: 3008890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domain.
    Jorieux S; Gaucher C; Piétu G; Chérel G; Meyer D; Mazurier C
    Br J Haematol; 1994 May; 87(1):113-8. PubMed ID: 7524613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains.
    van der Plas RM; Gomes L; Marquart JA; Vink T; Meijers JC; de Groot PG; Sixma JJ; Huizinga EG
    Thromb Haemost; 2000 Dec; 84(6):1005-11. PubMed ID: 11154106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of binding sites within human von Willebrand factor for monomeric type III collagen.
    Roth GJ; Titani K; Hoyer LW; Hickey MJ
    Biochemistry; 1986 Dec; 25(26):8357-61. PubMed ID: 3493805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen.
    Sixma JJ; Sakariassen KS; Stel HV; Houdijk WP; In der Maur DW; Hamer RJ; de Groot PG; van Mourik JA
    J Clin Invest; 1984 Sep; 74(3):736-44. PubMed ID: 6332119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of ADAMTS13 peptide sequences binding to von Willebrand factor.
    Moriki T; Maruyama IN; Igari A; Ikeda Y; Murata M
    Biochem Biophys Res Commun; 2010 Jan; 391(1):783-8. PubMed ID: 19944670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional analysis of a recombinant glycoprotein Ib alpha polypeptide which inhibits von Willebrand factor binding to the platelet glycoprotein Ib-IX complex and to collagen.
    Cruz MA; Petersen E; Turci SM; Handin RI
    J Biol Chem; 1992 Jan; 267(2):1303-9. PubMed ID: 1730650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673.
    Christophe O; Obert B; Meyer D; Girma JP
    Blood; 1991 Nov; 78(9):2310-7. PubMed ID: 1834252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventional thermal injury of the arterial wall: unfolding of von Willebrand factor and its increased binding to collagen after 55 degrees C heating.
    Post MJ; de Graaf-Bos AN; Posthuma G; de Groot PG; Sixma JJ; Borst C
    Thromb Haemost; 1996 Mar; 75(3):515-9. PubMed ID: 8701418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
    Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP
    Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adhesion of blood platelets is inhibited by VCL, a recombinant fragment (leucine504 to lysine728) of von Willebrand factor.
    Sixma JJ; Ijsseldijk MJ; Hindriks G; van Zanten GH; Gorecki M; Panet A; Garfinkel LI; de Groot PG
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):64-71. PubMed ID: 8548428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen.
    Ribba AS; Loisel I; Lavergne JM; Juhan-Vague I; Obert B; Cherel G; Meyer D; Girma JP
    Thromb Haemost; 2001 Sep; 86(3):848-54. PubMed ID: 11583318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
    Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
    Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen.
    Denis C; Baruch D; Kielty CM; Ajzenberg N; Christophe O; Meyer D
    Arterioscler Thromb; 1993 Mar; 13(3):398-406. PubMed ID: 8443144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The collagen-binding leech products rLAPP and calin prevent both von Willebrand factor and alpha2beta1(GPIa/IIa)-I-domain binding to collagen in a different manner.
    Depraetere H; Kerekes A; Deckmyn H
    Thromb Haemost; 1999 Sep; 82(3):1160-3. PubMed ID: 10494781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the collagen-binding site of the von Willebrand factor A3-domain.
    Romijn RA; Bouma B; Wuyster W; Gros P; Kroon J; Sixma JJ; Huizinga EG
    J Biol Chem; 2001 Mar; 276(13):9985-91. PubMed ID: 11098050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey model.
    Ji S; Jiang M; Yan B; Shen F; He Y; Wan A; Xia L; Ruan C; Zhao Y
    J Hematol Oncol; 2017 May; 10(1):111. PubMed ID: 28526067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III.
    Pareti FI; Niiya K; McPherson JM; Ruggeri ZM
    J Biol Chem; 1987 Oct; 262(28):13835-41. PubMed ID: 3498719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis of von Willebrand factor binding to platelet glycoprotein Ib and collagen. Effects of disulfide reduction and limited proteolysis of polymeric von Willebrand factor.
    Bockenstedt P; Greenberg JM; Handin RI
    J Clin Invest; 1986 Mar; 77(3):743-9. PubMed ID: 2936763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.